+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastoma

The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastoma

Physics in Medicine and Biology 54(18): 5525-5539

The PET tracer O-(2-[18F]Fluoroethyl)-l-tyrosine (FET) has been shown to be valuable for different roles in the management of brain tumours. The aim of this study was to evaluate several quantitative measures of dynamic FET PET imaging in patients with resected glioblastoma. We evaluated dynamic FET PET in nine patients with histologically confirmed glioblastoma. Following FET PET, all subjects had radiation and chemotherapy. Tumour ROIs were defined by a threshold-based region-growing algorithm. We compared several standard measures of tumour uptake and uptake kinetics: SUV, SUV/background, distribution volume ratio (DVR), weighted frame differences and compartment model parameters. These measures were correlated with disease-free and overall survival, and analysed for statistical significance. We found that several measures allowed robust quantification. SUV and distribution volume did not correlate with clinical outcome. Measures that are based on a background region (SUV/BG, Logan-DVR) highly correlated with disease-free survival (r = -0.95, p < 0.0001), but not overall survival. Some advanced measures also showed a prognostic value but no improvement over the simpler methods. We conclude that FET PET probably has a prognostic value in patients with resected glioblastoma. The ratio of SUV to background may provide a simple and valuable predictive measure of the clinical outcome. Further studies are needed to confirm these explorative results.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 056452172

Download citation: RISBibTeXText

PMID: 19717889

DOI: 10.1088/0031-9155/54/18/012

Related references

Correlation of Tumor Perfusion Between Carbon-13 Imaging with Hyperpolarized Pyruvate and Dynamic Susceptibility Contrast MRI in Pre-Clinical Model of Glioblastoma. Molecular Imaging and Biology 21(4): 626-632, 2019

Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab. Clinical and Translational Oncology 21(10): 1413-1423, 2019

Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor. Radiology 272(2): 484-493, 2014

Digital image correlation: a novel dynamic three-dimensional imaging technique for precise quantification of the dynamic rhytid and botulinum toxin type a efficacy. Plastic and Reconstructive Surgery 135(5): 869e-876e, 2015

Correlation of MicroRNA 132 Up-regulation with an Unfavorable Clinical Outcome in Patients with Primary Glioblastoma Multiforme Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide Chemotherapy. Translational Oncology 6(6): 742-748, 2013

Quantification of supra-aortic arterial wall inflammation in patients with arteritis using high resolution dynamic contrast-enhanced magnetic resonance imaging: initial results in correlation to [18F]-FDG PET/CT. Investigative Radiology 46(9): 594-599, 2011

Quantification of dynamic posterior translation in modified bilateral Alexander views and correlation with clinical and radiological parameters in patients with acute acromioclavicular joint instability. Archives of Orthopaedic and Trauma Surgery 137(6): 845-852, 2017

Impact of extent of resection and recurrent surgery on clinical outcome and overall survival in a consecutive series of 170 patients for glioblastoma in intraoperative high field magnetic resonance imaging. Journal of Neurosurgical Sciences 61(3): 233-244, 2017

The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model. Neurological Research 30(9): 952-959, 2008

Excellent correlation of FDG pet imaging with clinical outcome in patients with neurofibromatosis type 1 and low grade astrocytomas. Journal of Nuclear Medicine 40(5 Suppl. ): 129P, 1999

Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab. International Journal of Oncology 41(3): 1029-1035, 2012

Dynamic quantitative intravital imaging of glioblastoma progression reveals a lack of correlation between tumor growth and blood vessel density. Plos one 8(9): E72655, 2013

Arterial hypertension and bevacizumab treatment in glioblastoma: no correlation with clinical outcome. Journal of Neuro-Oncology 97(1): 157-158, 2010

Immunophenotypic characterization of human glioblastoma stem cells: correlation with clinical outcome. Journal of Cellular Biochemistry 116(5): 864-876, 2015

Reliability of gadolinium-enhanced magnetic resonance imaging findings and their correlation with clinical outcome in patients with sciatica. Spine Journal 14(11): 2598-2607, 2014